Kiadis Pharma
Engaged in the clinical development and commercialization of cell-based immunotherapy products for treatment of blood cancer and blood disorders.
Enterprise value
$183m
Share price
€5.46 KDS.AS
Company register number
63512653
Recent deals
Authorizing premium user...